Ingo Klare

6.6k citations

98 papers · 4.4k indexed · h-index 36

Impact in

Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Clinical Biochemistry 44
- Bacterial Identification and Susceptibility Testing 44
Infectious Diseases 79
- Antimicrobial Resistance in Staphylococcus 73
- Antifungal resistance and susceptibility 8

Co-authors: Wolfgang Witte (54 shared papers)Guido Werner (55 shared papers)Carola Konstabel (10 shared papers)H. Claus (4 shared papers)H. Heier (5 shared papers)Rolf Reissbrodt (3 shared papers)Carola Fleige (15 shared papers)Geert Huys (5 shared papers)
Journals: Journal of Antimicrobial Chemotherapy (7 papers)Journal of Clinical Microbiology (7 papers)Microbial Drug Resistance (5 papers)International Journal of Antimicrobial Agents (4 papers)International Journal of Medical Microbiology (4 papers)
Partner nations: Germany Netherlands Belgium

In The Last Decade

Ingo Klare

97 papers receiving 4.2k citations

Peers

Countries citing papers authored by Ingo Klare

Since Specialization

Citations

This map shows the geographic impact of Ingo Klare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Klare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Klare more than expected).

Fields of papers citing papers by Ingo Klare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Klare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Klare. The network helps show where Ingo Klare may publish in the future.

Co-authors

The 25 scholars most cited alongside Ingo Klare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ingo Klare Line = papers co-authored together Ingo Klare links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use Journal of Antimicrobial Chemotherapy ·Ingo Klare, Carola Konstabel, Guido Werner, Geert Huys, Vanessa Vankerckhoven, Gunnar Kahlmeter, Bianca Hildebrandt, Sibylle Müller-Bertling, Wolfgang Witte, Herman Goossens	2007	284
2	vanA-mediated high-level glycopeptide resistance inEnterococcus faeciumfrom animal husbandry FEMS Microbiology Letters ·Ingo Klare, H. Heier, H. Claus, Rolf Reissbrodt, Wolfgang Witte	1995	256
3	Evaluation of New Broth Media for Microdilution Antibiotic Susceptibility Testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria Applied and Environmental Microbiology ·Ingo Klare, Carola Konstabel, Sibylle Müller-Bertling, Rolf Reissbrodt, Geert Huys, Marc Vancanneyt, Jean Swings, Herman Goossens, Wolfgang Witte	2005	217
4	Enterococcus faecium Strains with vanA -Mediated High-Level Glycopeptide Resistance Isolated from Animal Foodstuffs and Fecal Samples of Humans in the Community Microbial Drug Resistance ·Ingo Klare, H. Heier, H. Claus, G Böhme, Silvia Marín, G. Seltmann, Regine Hakenbeck, V. ANTANASSOVA, Wolfgang Witte	1995	216
5	Decreased Incidence of VanA-type Vancomycin-Resistant Enterococci Isolated from Poultry Meat and from Fecal Samples of Humans in the Community after Discontinuation of Avoparcin Usage in Animal Husbandry Microbial Drug Resistance ·Ingo Klare, Dietlinde Badstübner, Carola Konstabel, G Böhme, H. Claus, Wolfgang Witte	1999	207
6	A Potential Virulence Gene,hyl_Efm, Predominates inEnterococcus faeciumof Clinical Origin The Journal of Infectious Diseases ·Louis B. Rice, Lenore L. Carias, Susan D. Rudin, Carl Vael, Herman Goossens, Carola Konstabel, Ingo Klare, Sreedhar R. Nallapareddy, Wenxiang Huang, Barbara E. Murray	2003	205
7	Occurrence and spread of antibiotic resistances in Enterococcus faecium International Journal of Food Microbiology ·Ingo Klare, Carola Konstabel, Dietlinde Badstübner, Guido Werner, Wolfgang Witte	2003	196
8	Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals European Journal of Clinical Microbiology & Infectious Diseases ·Ingo Klare, Carola Konstabel, S. Mueller-Bertling, Guido Werner, Birgit Strommenger, Christiane Kettlitz, Stefan Borgmann, Berit Schulte, Daniel E Jonas, Annerose Serr, A. Fahr, Ulrich Eigner, Wolfgang Witte	2005	132
9	Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project Trends in Food Science & Technology ·Vanessa Vankerckhoven, Geert Huys, Marc Vancanneyt, Carl Vael, Ingo Klare, Marie‐Bénédicte Romond, José M. Entenza, Philippe Moreillon, Richèle D. Wind, Jan Knol, Emmanuel J. H. J. Wiertz, Bruno Pot, Elaine E. Vaughan, Gunnar Kahlmeter, Herman Goossens	2007	132
10	Tigecycline resistance in clinical isolates ofEnterococcus faeciumis mediated by an upregulation of plasmid-encoded tetracycline determinantstet(L) andtet(M) Journal of Antimicrobial Chemotherapy ·S. Fiedler, Jennifer K. Bender, Ingo Klare, Sven Halbedel, Elisabeth Grohmann, Ulrich Szewzyk, Guido Werner	2015	104
11	In Vitro Susceptibility of Multidrug Resistant Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD) Plasma Processes and Polymers ·Georg Daeschlein, Matthias Napp, Sebastian von Podewils, Stine Lutze, Steffen Emmert, Anja Lange, Ingo Klare, Hermann Haase, Denis Gümbel, Thomas von Woedtke, Michael Jünger	2013	102
12	How many infections are caused by patient-to-patient transmission in intensive care units?* Critical Care Medicine ·Hajo Grundmann, Sina Bärwolff, Adriana Tami, Michael Behnke, Frank Schwab, Christine Geffers, E Halle, Ulf B. Göbel, R. Schiller, Daniel E Jonas, Ingo Klare, Klaus Weist, Wolfgang Witte, Kathrin Beck-Beilecke, Martin Schumacher, H. Rüden, Petra Gastmeier	2005	98
13	IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium BMC Infectious Diseases ·Guido Werner, Carola Fleige, Uta Geringer, Willem van Schaik, Ingo Klare, Wolfgang Witte	2011	97
14	Environmental strains ofEnterococcus faeciumwith inducible high-level resistance to glycopeptides FEMS Microbiology Letters ·Ingo Klare, H. Heier, H. Claus, Wolfgang Witte	1993	92
15	Occurrence of antibiotic‐resistant enterobacteria in agricultural foodstuffs Molecular Nutrition & Food Research ·Sybille Boehme, Guido Werner, Ingo Klare, Rolf Reissbrodt, Wolfgang Witte	2004	89
16	Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe Journal of Antimicrobial Chemotherapy ·Alicja Kuch, Rob J. L. Willems, Guido Werner, Teresa M. Coque, Anette M. Hammerum, Arnfinn Sundsfjord, Ingo Klare, Patricia Ruíz-Garbajosa, Gunnar Skov Simonsen, Miranda van Luit‐Asbroek, Waleria Hryniewicz, Ewa Sadowy	2011	88
17	Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens International Journal of Medical Microbiology ·Wolfgang Witte, Christiane Cuny, Ingo Klare, Ulrich Nübel, Birgit Strommenger, Guido Werner	2008	84
18	Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting Journal of Clinical Microbiology ·Yvonne Gräser, Ingo Klare, E Halle, R. Gantenberg, Petra Buchholz, H D Jacobi, W Presber, Gabriele Schönian	1993	79
19	Quinupristin/Dalfopristin-Resistant Enterococci of the satA ( vatD ) and satG ( vatE ) Genotypes from Different Ecological Origins in Germany Microbial Drug Resistance ·Guido Werner, Ingo Klare, H. Heier, K.‐H. Hinz, G Böhme, Michael Wendt, Wolfgang Witte	2000	63
20	Inducible carboxypeptidase activity in vancomycin-resistant enterococci Antimicrobial Agents and Chemotherapy ·Ludwig Gutmann, D Billot-Klein, S. Al-Obeid, Ingo Klare, S. Francoual, E. Collatz, Jean van Heijenoort	1992	62

About Ingo Klare

Ingo Klare is a scholar working on Clinical Biochemistry, Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 98 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (73 papers), Bacterial Identification and Susceptibility Testing (44 papers), Antibiotic Resistance in Bacteria (21 papers), Streptococcal Infections and Treatments (15 papers), Probiotics and Fermented Foods (15 papers), Bacterial biofilms and quorum sensing (11 papers), Mycobacterium research and diagnosis (9 papers) and Antifungal resistance and susceptibility (8 papers). The work is most often cited by research in Clinical Biochemistry (1.4k citations), Molecular Medicine (918 citations), Infectious Diseases (2.5k citations), Applied Microbiology and Biotechnology (151 citations) and Food Science (1.2k citations). Ingo Klare has collaborated with scholars based in Germany, Netherlands and Belgium. Frequent co-authors include Wolfgang Witte, Guido Werner, Carola Konstabel, H. Claus, H. Heier, Rolf Reissbrodt, Carola Fleige, Geert Huys, Jennifer K. Bender and G Böhme. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology, Microbial Drug Resistance, International Journal of Antimicrobial Agents and International Journal of Medical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact